Wednesday, January 06, 2021 4:58:37 PM
I need a bigger rake to scoop up all this cash trade....
Recent INMB News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:17:07 PM
- INmune Bio Inc. Announces First Quarter 2026 Results and Provides Business Update • GlobeNewswire Inc. • 05/07/2026 08:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 08:30:19 PM
- INmune Bio and Anthony Nolan Announce Strategic Expansion of CORDStrom™ MSC Platform Collaboration to Target RDEB, Oncology, and Inflammatory Diseases • GlobeNewswire Inc. • 05/05/2026 08:00:00 PM
- INmune Bio Inc. to Report First Quarter 2026 Financial Results and Provide Corporate Update on Thursday, May 7th • GlobeNewswire Inc. • 04/30/2026 12:00:00 PM
- INmune Bio Inc. Announces New Preclinical Data at AACR 2026 Demonstrating INB03 (XPro1595) Overcomes Resistance and Reduces Metastases in HER2-Positive Breast Cancer Models • GlobeNewswire Inc. • 04/16/2026 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:29:24 PM
- INmune Bio Inc. Announces 2025 Results and Provides Business Update • GlobeNewswire Inc. • 03/30/2026 08:00:00 PM
- INmune Bio Inc. to Report Year End 2025 Financial Results and Provide Corporate Update on Monday, March 30th. • GlobeNewswire Inc. • 03/24/2026 12:00:00 PM
- INmune Bio’s MINDFuL Trial Featured at AD/PD 2026 Plenary as Successful Example of How to Approach Clinical Trials Targeting Inflammation in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/19/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2026 02:14:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2026 09:05:29 PM
- INmune Bio to Detail XPro1595 Registrational Strategy in Upcoming Alzheimer’s Webinar • GlobeNewswire Inc. • 02/23/2026 02:25:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2026 09:00:25 PM
- INmune Bio Announces Upcoming Webinar to Present New Clinical Data on CORDStrom™ for RDEB • GlobeNewswire Inc. • 02/19/2026 05:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2026 09:00:31 PM
- INmune Bio Announces FDA Alignment on Integrated Phase 2b/3 Registration Pathway for XPro1595 in Early Alzheimer’s Disease • GlobeNewswire Inc. • 02/12/2026 12:00:00 PM
- INmune Bio Advances CORDStrom™ Towards UK Marketing Authorization in RDEB • GlobeNewswire Inc. • 02/10/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/27/2026 09:00:38 PM
- INmune Bio Inc Issues Shareholder Letter Reviewing 2025 Milestones and Outlining 2026 Strategic Initiatives • GlobeNewswire Inc. • 01/27/2026 02:25:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2025 09:00:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2025 09:30:33 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/19/2025 09:00:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/10/2025 09:00:38 PM
- Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend] • Edgar (US Regulatory) • 12/08/2025 09:30:01 PM
